Changes to the Roche Enlarged Corporate Executive Committee

Roche today announced that John C. Reed (1958), MD, PhD, Head of Roche Pharma Research and Early Development (pRED) since 2013, has decided to leave Roche for personal reasons and will return to the United States effective 2 April 2018.
Source: Roche Media News - Category: Pharmaceuticals Source Type: news